We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App




Recurrent Mutation Linked to Childhood Blindness

By LabMedica International staff writers
Posted on 29 May 2017
Researchers have identified a genetic mutation that contributes to the sight loss that occurs in children with ocular coloboma, a developmental defect that causes part of the eye to be missing at birth. More...
The findings shed light on its causes and help explain how genes contribute to development of the eye.

Ocular coloboma is a developmental defect in optic fissure closure and is a common cause of severe congenital visual impairment. Coloboma can have profound, devastating effects on visual ability, accounting for up to 10% of all childhood blindness. It can cause a distinctive keyhole-shaped pupil as it commonly results in a missing segment in the iris. However, coloboma is very variable and therefore likely to be caused by a number of genes. Few genetic causes have so far been found to help explain the cause of coloboma.

The research team, led by Dr. Joe Rainger University of Edinburgh, worked with 12 families, studying the DNA of children with coloboma and their unaffected parents. Using state-of-the-art genetic screening by whole exome sequencing, the scientists revealed mutations in 10 genes, 3 of which were linked to activity of one molecule: actin, important for various vital cell functions, including in defining cell shape and structure via maintenance of the cytoskeleton.

Targeted gene sequencing was then carried out on a further 380 people with coloboma. This showed that one of the mutations – a specific alteration in the gene ACTG1 – recurred across a number of those tested. The scientists edited this ACTG1 mutation into a line of mice using cutting-edge CRISPR/Cas9 gene-editing technology, and found that it had severe effects on actin function.

The newly identified mutations are thought to affect how actin binds to other proteins and on actin stability, which could severely affect development of the eye in the womb. The findings add knowledge to our understanding of coloboma onset as well as on the importance of actin to eye development.

The study, by Rainger J et al, was published May 11, 2017, in the journal Human Mutation.


Gold Member
Veterinary Hematology Analyzer
Exigo H400
Serological Pipet Controller
PIPETBOY GENIUS
New
Shaking Incubator
Corning LSE 71L
New
Glucose Tolerance Test
NERL Trutol
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Microbiology

view channel
Image: The U.S. FDA-cleared IntelliSep rapid host response diagnostic represents a breakthrough in sepsis care (Photo courtesy of Cytovale)

Rapid Diagnostic Test Slashes Sepsis Mortality by 39%

Sepsis remains one of the most challenging and fatal conditions in contemporary healthcare, accounting for nearly one-third of all hospital-related deaths in the United States. In emergency departments... Read more

Industry

view channel
Image: The knowledge transfer partnership will further develop technology to rapidly diagnose serious and high-risk infectious diseases (Photo courtesy of Aston University)

Aston University and BG Research Partner to Commercialize Groundbreaking Medical Diagnostic

Technology that can rapidly diagnose high-consequence infectious diseases will take a major step forward towards commercialization, thanks to a new partnership. A Knowledge Transfer Partnership (KTP)... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.